Navigation Links
ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
Date:1/31/2008

ctivity against HIV-1, HIV-2, human and avian influenza viruses, and herpes simplex viruses 1 and 2 (HSV-1 and HSV-2).

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. The Company seeks to improve the performance and safety of existing treatments by addressing significant problems, such as drug metabolism and bioavailability, excessive toxicity and treatment resistance. More information can be found on ADVENTRX's web site at http://www.adventrx.com.

Forward Looking Statement

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the validity of research results; the risk that preclinical results are not indicative of the success of subsequent clinical trials and that products will not perform as preclinical data suggests or as otherwise anticipated; unexpected adverse side effects or inadequate therapeutic efficacy of ADVENTRX's product candidates and other uncertainties inherent in the drug development process; the timing and success of clinical trials; difficulties or delays in developing, testing, manufacturing, and obtaining regulatory approval for ADVENTRX's product candidates; the risk that ADVENTRX will be unable to raise sufficient capital to fund the projects necessary to meet its anticipated or stated goals and milestones; and other risks and uncertainties more fully described in ADVENTRX's press releases and public filings
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
7. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015  Echo Therapeutics, Inc. (NASDAQ: ... non-invasive continuous glucose monitoring and associated technologies, today ... re-designed corporate website echotx.com . Echo,s new ... technology and enhances the quality and availability of ... communicates to prospective customers and stakeholders what Echo ...
(Date:7/1/2015)... , July 1, 2015 Dynatronics ... manufacturer and marketer of rehabilitation and physical therapy ... $4,025,000 private placement financing led by affiliates of ... equity investor focused on the healthcare industry. The ... organic growth and pursue potential strategic acquisitions.  ...
(Date:7/1/2015)... 2015 ExeGi Pharma, a company focused on ... today that it has been granted a product license ... Directorate (NNHPD) to sell Visbiome™ in Canada ... Professor Claudio De Simone , MD, PhD and ... De Simone recently signed an exclusive agreement with ExeGi ...
Breaking Medicine Technology:Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3
... 5, 2011 Dendreon Corporation (Nasdaq: DNDN ) ... J.P. Morgan Healthcare Conference in San Francisco on January 10, ... will be audio webcast live and available for replay from ... listen to the live webcast, it will be archived on ...
... Nev., Jan. 5, 2011 PDL BioPharma, Inc. ... P. McLaughlin, the company,s president and chief executive officer, is ... Conference in San Francisco at 7:30 a.m. Pacific time. ... a live and archived audio webcast. To access the live ...
Cached Medicine Technology:
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. Jian-Dong Li, a ... and a Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received ... infections. , The grant from the National Institute on Deafness and Other Communication ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... land of liberty. Americans have been arguing over laws governing sexuality since the ... period, as a forthcoming historical comparative biography by Cindy Safronoff reveals. Crossing Swords: ...
(Date:7/1/2015)... ... 2015 , ... A healthy eating plan concentrates on foods ... organic foods and products can help limit the exposure to pesticides and chemical-based ... farming. Choosing home raised chickens and eggs that do not contain antibiotics are ...
(Date:7/1/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich , ... March 6th - 8th, the 2016 meeting will be held at the Westin Galleria ... nasal surgery through the most modern advancements and updates in rhinoplasty and revision ...
(Date:7/1/2015)... ... 2015 , ... Did you know that infertility in men is more common ... Advanced Fertility Center of Texas (AFCT) would like to talk about some natural ways ... considered to be a “woman’s issue,” male fertility factors can play a role in ...
Breaking Medicine News(10 mins):Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4
... up to Take Control of Health, Take off Pounds to ... Gain ... a year makes!,What a difference people can make when they join together ... Washington,D.C. to join Dr. Ian Smith, Patti LaBelle, Yolanda Adams, Michael Strahan,Steve ...
... a,Washington, D.C.-based research, evaluation and consulting organization,today released ... finds,low awareness and knowledge levels about HIV/AIDS, but ... important predictors for heightened,awareness., Some key findings ... -- Only 1 percent of respondents were ...
... April 2, 2008 The Richard B. and,Lynne V. ... the Institute,s Board of Directors. As a director, she ... "We are delighted to have Mary Cheney join ... of the Cheney family,actively involved in shaping the major ...
... Oaks,Development Group announced today the company has closed on ... behind St. David Medical Center in Austin,Texas. A 29,724-square-foot ... being converted to Oaks, unique tenant-ownership model., Oaks, ... limited liability,company (L.L.C.). Tenant partners split ownership interest of ...
... Sky,One Medical, Inc. (OTC Bulletin Board: CSKI) ("China Sky ... pharmaceutical,medicinal and diagnostic products in China, today announced record,financial ... December 31,2007., Fourth Quarter 2007 Highlights ... from the fourth quarter of ...
... stalled at just 9 percent, HARTFORD, Conn., April ... need to re-examine its value proposition to break,out of ... broader market,according to a new study by Conning Research ... sold primarily by specialist agents,to a niche market of ...
Cached Medicine News:Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 2Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 3Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 4Health News:Education and Media Key to Improving HIV/AIDS Awareness and Knowledge Levels in Afghanistan, New InterMedia Report Says 2Health News:Education and Media Key to Improving HIV/AIDS Awareness and Knowledge Levels in Afghanistan, New InterMedia Report Says 3Health News:Mary Cheney Joins the Cheney Cardiovascular Institute Board of Directors 2Health News:Oaks Development Group Acquires Medical Office Building in Austin, Texas 2Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 2Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 3Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 4Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 5Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 6Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 7Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 8Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 9Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 10Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 11Health News:Conning Research: Long Term Care Insurance Industry Continues to Search for Broader Market 2
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide smooth handle with polished finish....
Ergotec Vetriretinal Instrument System. Fine angled tips (3 mm). 20 gauge shaft length with black tip. Overall length from rear rotation knob to tip....
Ergotec Vetriretinal Instrument System. Ultra-fine 0.8 mm tips. Angled 40 degrees. 20 gauge shaft tapers to 23 gauge....
Ergotec Vetriretinal Instrument System. Ultra-fine 2.8 mm jaws. Angled 55 degrees. 20 gauge shaft. 25 mm in length with black tip. Overall length from rear rotation knob to tip....
Medicine Products: